Chemoproteomic identification of molecular targets of antifungal prototypes, thiosemicarbazide and a camphene derivative of thiosemicarbazide, in Paracoccidioides brasiliensis.

PLoS One 2018 27;13(8):e0201948. Epub 2018 Aug 27.

Laboratório de Biologia Molecular, Instituto de Ciências Biológicas, Universidade Federal de Goiás, Goiânia, Goiás, Brazil.

Paracoccidioidomycosis (PCM) is a neglected human systemic disease caused by species of the genus Paracoccidioides. The disease attacks the host's lungs and may disseminate to many other organs. Treatment involves amphotericin B, sulfadiazine, trimethoprim-sulfamethoxazole, itraconazole, ketoconazole, or fluconazole. The treatment duration is usually long, from 6 months to 2 years, and many adverse effects may occur in relation to the treatment; co-morbidities and poor treatment adherence have been noted. Therefore, the discovery of more effective and less toxic drugs is needed. Thiosemicarbazide (TSC) and a camphene derivative of thiosemicarbazide (TSC-C) were able to inhibit P. brasiliensis growth at a low dosage and were not toxic to fibroblast cells. In order to investigate the mode of action of those compounds, we used a chemoproteomic approach to determine which fungal proteins were bound to each of these compounds. The compounds were able to inhibit the activities of the enzyme formamidase and interfered in P. brasiliensis dimorphism. In comparison with the transcriptomic and proteomic data previously obtained by our group, we determined that TSC and TSC-C were multitarget compounds that exerted effects on the electron-transport chain and cell cycle regulation, increased ROS formation, inhibited proteasomes and peptidases, modulated glycolysis, lipid, protein and carbohydrate metabolisms, and caused suppressed the mycelium to yeast transition.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201948PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110461PMC
February 2019
20 Reads

Publication Analysis

Top Keywords

derivative thiosemicarbazide
8
camphene derivative
8
investigate mode
4
mode action
4
compounds
4
order investigate
4
toxic fibroblast
4
fibroblast cells
4
cells order
4
action compounds
4
compounds chemoproteomic
4
bound compounds
4
compounds compounds
4
compounds inhibit
4
inhibit activities
4
proteins bound
4
fungal proteins
4
chemoproteomic approach
4
approach determine
4
determine fungal
4

References

(Supplied by CrossRef)
Species boundaries in the human pathogen Paracoccidioides
DA Turissini et al.
Fungal Genet Biol 2017
Brazilian guidelines for the clinical management of paracoccidioidomycosis
MA Shikanai-Yasuda et al.
Rev Soc Bras Med Trop 2017
Consenso em paracoccidioidomicose
MA Shikanai-Yasuda et al.
Rev Soc Bras Med Trop 2006
Drugs for treating paracoccidioidomycosis
V da Mota Menezes et al.
Cochrane Database Syst Rev 2006
Disseminated paracoccidioidomycosis: correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulphamethoxazole
RC Hahn et al.
Mycoses 2003

Similar Publications